GATA2 and chronic myelogenous leukemia, BCR-ABL1 positive: GATA2-L359V mutation, initially identified in patients with myelomonocytic transformation of chronic myelogenous leukemia (CML)22, also exists in patients with AML and is associated with poor prognosis16,23.